GHK-Cu (Copper Tripeptide-1) vs KLOW Stack (GHK-Cu + TB-500 + BPC-157 + KPV)

GHK-Cu (Copper Tripeptide-1)

GHK-Cu is the copper(II) complex of glycyl-L-histidyl-L-lysine, a tripeptide first isolated from human plasma. The free peptide binds copper with high affinity, and the complex is also known by the ingredient name copper tripeptide-1. Published work falls into three groups: cell-culture studies with fibroblasts and other skin-derived cells, wound and tissue models in animals, and a smaller number of studies of topical preparations in human volunteers. The human studies are mostly small and come from cosmetic research rather than controlled clinical trials. Reports that it alters the expression of large numbers of genes rest largely on reanalysis of gene-expression data from cultured cell lines, which shows association rather than a demonstrated effect in tissue.

KLOW Stack (GHK-Cu + TB-500 + BPC-157 + KPV)

This product is a blend of four research peptides, GHK-Cu, TB-500, BPC-157 and KPV, supplied together in one preparation. GHK-Cu is a copper-bound tripeptide first isolated from human plasma; TB-500 is the synthetic seven-residue fragment Ac-LKKTETQ from the actin-binding region of thymosin β4; BPC-157 is a 15-residue synthetic peptide derived from a sequence in a gastric juice protein; and KPV is the C-terminal tripeptide of alpha-melanocyte-stimulating hormone. Each component has been studied on its own, mostly in cell culture and animal models. No published work has examined the four in combination, and data on their chemical stability together are lacking, so the blend has no literature of its own.

How GHK-Cu (Copper Tripeptide-1) acts

GHK holds copper(II) through the amino nitrogen of glycine, a deprotonated backbone nitrogen and the imidazole ring of histidine, giving a complex that is stable at neutral pH. One proposed role is as a carrier that moves copper between plasma proteins and cells. Copper is a cofactor for lysyl oxidase, the enzyme that cross-links collagen and elastin, and fibroblast culture studies have reported changes in collagen and glycosaminoglycan synthesis on exposure to the complex. Animal wound studies have also looked at blood-vessel formation and inflammatory markers. How much of the reported activity belongs to the peptide and how much to the copper it carries has not been settled.

How KLOW Stack (GHK-Cu + TB-500 + BPC-157 + KPV) acts

There is no described mechanism for the four-part blend, only separate observations on its components, made in separate models. GHK-Cu is a high-affinity copper complex that has been examined in fibroblast culture. TB-500 copies the central actin-binding motif of thymosin β4, a protein that sequesters monomeric actin. BPC-157 has been examined in rodent studies of nitric oxide and VEGF receptor signalling without a settled target. KPV has been reported in cell lines to lower NF-κB activation, possibly after uptake through the PepT1 transporter. No study has asked whether these peptides interact chemically or biologically when combined, so no joint action can be described.

The records side by side

• Type: GHK-Cu (Copper Tripeptide-1), Copper tripeptide complex; KLOW Stack (GHK-Cu + TB-500 + BPC-157 + KPV), Four-peptide blend
• Length: GHK-Cu (Copper Tripeptide-1), 3 amino acids; KLOW Stack (GHK-Cu + TB-500 + BPC-157 + KPV), not recorded
• Molecular weight: GHK-Cu (Copper Tripeptide-1), 400.90 g/mol; KLOW Stack (GHK-Cu + TB-500 + BPC-157 + KPV), not recorded
• Molecular formula: GHK-Cu (Copper Tripeptide-1), C14H21CuN6O4-; KLOW Stack (GHK-Cu + TB-500 + BPC-157 + KPV), not recorded

Reading a comparison

A comparison places two records side by side; it does not merge them. Each description above is drawn from that compound's own record, and the two were not necessarily characterised by the same methods, at the same time, or to the same level of detail. Before comparing any attribute, it is worth establishing that both records describe the substance you think they describe — names are not identifiers, and two entries sharing a name can differ in salt form, stereochemistry or the convention used to state a mass. Where a figure carries no method beside it, the comparison is between two reported numbers rather than between two measurements.